161 related articles for article (PubMed ID: 30755142)
1. Refractory lupus nephritis: a survey.
Weidenbusch M; Bai Y; Eder J; Anders HJ;
Lupus; 2019 Apr; 28(4):455-464. PubMed ID: 30755142
[TBL] [Abstract][Full Text] [Related]
2. Differences in rituximab use between pediatric rheumatologists and nephrologists for the treatment of refractory lupus nephritis and renal flare in childhood-onset SLE.
Gilbert M; Goilav B; Hsu JJ; Nietert PJ; Meidan E; Chua A; Ardoin SP; Wenderfer SE; von Scheven E; Ruth NM;
Pediatr Rheumatol Online J; 2021 Aug; 19(1):137. PubMed ID: 34461932
[TBL] [Abstract][Full Text] [Related]
3. Approach to Membranous Lupus Nephritis: A Survey of Pediatric Nephrologists and Pediatric Rheumatologists.
Boneparth A; Radhakrishna SM; Greenbaum LA; Yen E; Okamura DM; Cooper JC; Mason S; Levy DM; Sule SD; Jensen PT; Yildirim-Toruner C; Ardoin SP; Wenderfer SE
J Rheumatol; 2017 Nov; 44(11):1619-1623. PubMed ID: 28916546
[TBL] [Abstract][Full Text] [Related]
4. Practice Patterns and Approach to Childhood Lupus Nephritis in Saudi Arabia.
AlMutairi A; Al-Mayouf SM; Kari J; Basahl E; Nashawi M
Saudi J Kidney Dis Transpl; 2023 Nov; 34(6):576-591. PubMed ID: 38725208
[TBL] [Abstract][Full Text] [Related]
5. Non-albumin proteinuria as a parameter of tubulointerstitial inflammation in lupus nephritis.
Kwon OC; Park Y; Lee JS; Oh JS; Kim YG; Lee CK; Yoo B; Hong S
Clin Rheumatol; 2019 Jan; 38(1):235-241. PubMed ID: 30094751
[TBL] [Abstract][Full Text] [Related]
6. Screening for proteinuria in patients with lupus: a survey of practice preferences among American rheumatologists.
Siedner MJ; Christopher-Stine L; Astor BC; Gelber AC; Fine DM
J Rheumatol; 2007 May; 34(5):973-7. PubMed ID: 17444588
[TBL] [Abstract][Full Text] [Related]
7. Commentary on the Current Guidelines for the Diagnosis of Lupus Nephritis Flare.
Ayoub I; Birmingham D; Rovin B; Hebert L
Curr Rheumatol Rep; 2019 Feb; 21(4):12. PubMed ID: 30810824
[TBL] [Abstract][Full Text] [Related]
8. Research priorities in childhood-onset lupus: results of a multidisciplinary prioritization exercise.
Ardoin SP; Daly RP; Merzoug L; Tse K; Ardalan K; Arkin L; Knight A; Rubinstein T; Ruth N; Wenderfer SE; Hersh AO;
Pediatr Rheumatol Online J; 2019 Jul; 17(1):32. PubMed ID: 31262324
[TBL] [Abstract][Full Text] [Related]
9. Distinguishing C1q nephropathy from lupus nephritis.
Sharman A; Furness P; Feehally J
Nephrol Dial Transplant; 2004 Jun; 19(6):1420-6. PubMed ID: 15004260
[TBL] [Abstract][Full Text] [Related]
10. Overview of lupus nephritis management guidelines and perspective from Asia.
Mok CC; Yap DY; Navarra SV; Liu ZH; Zhao MH; Lu L; Takeuchi T; Avihingsanon Y; Yu XQ; Lapid EA; Lugue-Lizardo LR; Sumethkul V; Shen N; Chen SL; Chan TM;
Int J Rheum Dis; 2013 Dec; 16(6):625-36. PubMed ID: 24382275
[TBL] [Abstract][Full Text] [Related]
11. [Interdisciplinary consensus to management of lupus nephritis in Germany].
de Groot K
Z Rheumatol; 2007 Dec; 66(8):724, 726. PubMed ID: 17965864
[TBL] [Abstract][Full Text] [Related]
12. Urine neutrophil gelatinase-associated lipocalin to predict renal response after induction therapy in active lupus nephritis.
Satirapoj B; Kitiyakara C; Leelahavanichkul A; Avihingsanon Y; Supasyndh O
BMC Nephrol; 2017 Aug; 18(1):263. PubMed ID: 28778196
[TBL] [Abstract][Full Text] [Related]
13. Outcomes of multitarget therapy using mycophenolate mofetil and tacrolimus for refractory or relapsing lupus nephritis.
Choi CB; Won S; Bae SC
Lupus; 2018 May; 27(6):1007-1011. PubMed ID: 29448881
[TBL] [Abstract][Full Text] [Related]
14. Working Towards a Treat-to-Target Protocol in Juvenile Proliferative Lupus Nephritis - A Survey of Pediatric Rheumatologists and Nephrologists in Germany and Austria.
Vollbach K; Schuetz C; Hedrich CM; Speth F; Mönkemöller K; Brunner J; Neudorf U; Rietschel C; Hospach A; Kallinich T; Hinze C; Wagner N; Tönshoff B; Weber LT; Latta K; Thumfart J; Bald M; Wiemann D; Zappel H; Tenbrock K; Haffner D
Front Pediatr; 2022; 10():851998. PubMed ID: 35529329
[TBL] [Abstract][Full Text] [Related]
15. Analysis of the effectiveness and safety of rituximab in patients with refractory lupus nephritis: a chart review.
Contis A; Vanquaethem H; Truchetet ME; Couzi L; Rigothier C; Richez C; Lazaro E; Duffau P
Clin Rheumatol; 2016 Feb; 35(2):517-22. PubMed ID: 26762196
[TBL] [Abstract][Full Text] [Related]
16. Urinary CXCL-10/IP-10 and MCP-1 as markers to assess activity of lupus nephritis.
Abujam B; Cheekatla S; Aggarwal A
Lupus; 2013 May; 22(6):614-23. PubMed ID: 23629827
[TBL] [Abstract][Full Text] [Related]
17. Differences in management approaches for lupus nephritis within the UK.
Ibrahim ST; Edwards CJ; Ehrenstein MR; Griffiths B; Gordon C; Hewins P; Jayne D; Lightstone L; McLaren Z; Rhodes B; Vital EM; Reynolds JA
Rheumatol Adv Pract; 2024; 8(1):rkae017. PubMed ID: 38469156
[TBL] [Abstract][Full Text] [Related]
18. Development of an instrument to predict proliferative histological class in lupus nephritis based on clinical and laboratory data.
Silaide de Araújo Júnior A; Sato EI; Silva de Souza AW; Jennings F; Mastroianni Kirsztajn G; Sesso R; Dos Reis-Neto ET
Lupus; 2023 Feb; 32(2):216-224. PubMed ID: 36461171
[TBL] [Abstract][Full Text] [Related]
19. Practice patterns and approach to kidney biopsy in lupus: a collaboration of the Midwest Pediatric Nephrology Consortium and the Childhood Arthritis and Rheumatology Research Alliance.
Wenderfer SE; Lane JC; Shatat IF; von Scheven E; Ruth NM
Pediatr Rheumatol Online J; 2015 Jun; 13():26. PubMed ID: 26087651
[TBL] [Abstract][Full Text] [Related]
20. Tacrolimus is an alternative therapeutic option for the treatment of refractory lupus nephritis.
Lee T; Oh KH; Joo KW; Kim YS; Ahn C; Han JS; Kim S; Chin HJ
Lupus; 2010 Jul; 19(8):974-80. PubMed ID: 20581020
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
